Ainos CEO says AI Nose platform transitioning into industrial deployment

Ainos (AIMD) issued a letter from Chairman, President and CEO Eddy Tsai, which read in part, “I’m proud to share that the AI Nose platform is transitioning from validation-stage pilots into structured industrial deployment. The confirmed initial order of 1,400 AI Nose systems activates recurring subscription revenue under a three-year service structure totaling approximately $2.1 million. This milestone marks our progression from proof-of-concept validation to revenue-generating implementation within semiconductor manufacturing environments. This also reflects our vision to expand AI Nose from healthcare into the broader industrial market. The broader roadmap contemplates phased deployment of up to 20,000 AI Nose systems across customer facilities. If fully executed over time, this framework could support annual order values approaching $10 million. Advancement into subsequent phases remains subject to staged technical validation and formal contractual conversion with our customer…In parallel, AI Nose is undergoing validation testing within advanced semiconductor front-end fabrication facilities – among the most technically demanding industrial environments in the world. These evaluations will set the foundation for commercial integration in advanced wafer fabrication facilities. Successful validation would expand our industrial integration opportunities within capital-intensive wafer fabrication environments. We remain focused on disciplined execution, subscription activation, and scalable infrastructure expansion as we position scent as the next AI token – advancing the smell language model (SLM), strengthening Smell ID libraries, and building SmellTech, powered by AI Nose, as a foundational sensing infrastructure for industrial AI systems.”